2-amino-delta(2)-thiazoline-4-carboxylic acid
RN given refers to parent cpd
Also Known As:
2-amino-delta(2)-thiazolin-4-carbonic acid; 2-amino-delta(2)-thiazoline-4-carboxylic acid, hydrobromide; 2-aminothiazoline-4-CA; 2-aminothiazoline-4-carboxylic acid; 2-iminothiazolidine-4-carboxylic acid
Networked: 6
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Arai, Tomomi:
1 article
(11/2022)
|
2. | Hoshi, Tomoaki:
1 article
(11/2022)
|
3. | Nishio, Tadashi:
1 article
(11/2022)
|
4. | Nogami, Makoto:
1 article
(11/2022)
|
5. | Toukairin, Yoko:
1 article
(11/2022)
|
6. | Fan, Ruifang:
1 article
(03/2021)
|
7. | Jiang, Wenhui:
1 article
(03/2021)
|
8. | Kuang, Hongxuan:
1 article
(03/2021)
|
9. | Li, Yonghong:
1 article
(03/2021)
|
10. | Li, Zhilin:
1 article
(03/2021)
|
Related Diseases
1. | Poisoning
|
2. | Seizures (Absence Seizure)
|
3. | Asthma (Bronchial Asthma)
03/01/2021
- " Urinary 3-&4-Methylhippuric acid (3-&4-MHA, OR: 5.78, 95% CI: 3.50, 9.54), rac 2-Aminothiazoline-4-carboxylic acid (ATCA, OR: 2.90, 95% CI: 1.69, 4.99) and N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (DHBMA, OR: 2.76, 95% CI: 1.73, 4.43) which may derive from m/p-xylene, cyanide and 1,3-butadiene exposure, respectively, could significantly and maximally increase the odds of asthma. "
|
|
Related Drugs and Biologics